Will CVS Caremark add at least one other GLP-1 medication for weight loss (besides Zepbound) to its standard formulary by December 31, 2027?

CVS Caremark is restoring coverage for Zepbound. This question explores whether they will expand their formulary to include other GLP-1 drugs for weight loss, indicating a broader shift in coverage strategy. The resolution will be based on publicly available formulary updates from CVS Caremark.

Implied probability (Yes)

60%

Closes

2029-08-26